Deep knowledge on 
 small-molecule drugs and 
 the 100,000 global patents 
 covering them 

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

How are People Using DrugPatentWatch?

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: desmopressin acetate

« Back to Dashboard
Desmopressin acetate is the generic ingredient in nine branded drugs marketed by Apotex Inc, Sun Pharm Inds, Hospira, Ferring Pharms Inc, Teva Pharms, Bausch And Lomb, Glenmark Pharms Ltd, Ferring, Mylan Pharms Inc, Csl Behring, Actavis Labs Fl Inc, Sun Pharma Global, Bedford, Sun Pharm Inds Ltd, and Teva Pharms Usa, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for desmopressin acetate. Four suppliers are listed for this compound.

Summary for Generic Name: desmopressin acetate

Tradenames:9
Patents:0
Applicants:15
NDAs:21
Drug Master File Entries: see list18
Suppliers / Packaging: see list20
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)

Clinical Trials for: desmopressin acetate

The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion
Status: Completed Condition: Gender Difference in V2 Receptor Function in Response to dDAVP Infusion; Nocturia; Nocturnal Enuresis

Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia
Status: Completed Condition: Nocturia

Desmopressin Response in the Young
Status: Completed Condition: Primary Nocturnal Enuresis

Minirin Versus Oxybutynin for Nocturnal Enuresis in Children
Status: Completed Condition: Nocturnal Enuresis

Effect of Aspirin, Hemodilution and Desmopressin on Platelet Dysfunction
Status: Completed Condition: Platelet Dysfunction; Hemodilution; Mild Hypothermia; NSAID; Desmopressin

DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty
Status: Not yet recruiting Condition: Postoperative Ecchymosis

Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo
Status: Completed Condition: Nocturia

Analgesic Efficacy of Intranasal Desmopressin in Acute Renal Colic
Status: Recruiting Condition: Renal Colic; Pain

Pharmacokinetics and Pharmacodynamics of Desmopressin Oral Lyophilisate Formulation in the Paediatric Population
Status: Recruiting Condition: Monosymptomatic Nocturnal Enuresis

Study of DDAVP Combined With TXA on the Blood Loss and Transfusion Need During and After Scoliosis Correction Surgery
Status: Active, not recruiting Condition: Idiopathic Scoliosis

A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).
Status: Completed Condition: Central Diabetes Insipidus

An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults
Status: Completed Condition: Nocturia

Clinical Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients
Status: Terminated Condition: Nocturia; Obstructive Sleep Apnoea

Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson Disease
Status: Terminated Condition: Parkinson Disease

Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery
Status: Completed Condition: Acquired Von Willebrand Disease Secondary to Severe Aortic Stenosis; Heye´s Syndrome; Severe Aortic Stenosis

Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients
Status: Completed Condition: Nocturia

Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study
Status: Recruiting Condition: Nocturia

Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study
Status: Completed Condition: Nocturnal Polyuria

Desmopressin as Treatment for Postoperative Bleeding After Cardiac Surgery
Status: Terminated Condition: Hemorrhage; Postoperative Blood Loss

Desmopressin for Bleeding Related to Low Body Temperature
Status: Not yet recruiting Condition: Hypothermia Induced Impairment of Primary Haemostasis

Desmopressin Acetate 0.2 mg Tablets, Fasting
Status: Completed Condition: Healthy

Documentation of the Efficacy of Desmopressin Within the Context of Surgical Procedures
Status: Recruiting Condition: Platelet Dysfunction

Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers
Status: Enrolling by invitation Condition: Hemophilia A

Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis
Status: Completed Condition: Nocturnal Enuresis

Desmopressin in the Treatment of Mixed Nocturia With Nocturnal Polyuria and Low Nocturnal Bladder Capacity
Status: Completed Condition: Nocturia

Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older
Status: Not yet recruiting Condition: Nocturia

Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients
Status: Completed Condition: Nocturia

Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis
Status: Terminated Condition: Leptospirosis

Desmopressin Melt: Impact on Sleep and Daytime Functioning
Status: Completed Condition: Monosymptomatic Nocturnal Enuresis.

Perioperative Use of Desmopressin (DDAVP) in Breast Cancer
Status: Completed Condition: Breast Cancer

Efficacy and Safety of IL-11 in DDAVP Unresponsive
Status: Completed Condition: Hemophilia A; Von Willebrand Disease

1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy
Status: Completed Condition: Kidney Failure

Effects of Desmopressin on Blood Loss and the Quality of the Surgical Field During Endoscopic Sinus Surgery
Status: Recruiting Condition: Patients Undergoing Endoscopic Sinus Surgery

Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell Disease
Status: Not yet recruiting Condition: Nocturnal Enuresis; Anemia, Sickle Cell

Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept
Status: Completed Condition: Intracerebral Hemorrhage

Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding
Status: Recruiting Condition: Colorectal Cancer; Rectal Bleeding

Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction
Status: Completed Condition: Liver Cirrhosis; Coagulopathy

Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulation
Status: Completed Condition: Enuresis; Polyuria

Desmopressin for Improving Nocturnal Enuresis in Patients After Radical Cystectomy With Bladder Reconstruction
Status: Active, not recruiting Condition: Nocturnal Enuresis

Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Men
Status: Completed Condition: Nocturia

Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women
Status: Completed Condition: Nocturia

Effect of Desmopressin on Platelet Function in CKD Patients on Antiplatelet Drug
Status: Completed Condition: Bleeding; Tachycardia; Dyspnea

A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)
Status: Completed Condition: Primary Nocturnal Enuresis

A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis
Status: Completed Condition: Nocturnal Enuresis

Desmopressin in Cardiac Surgery
Status: Completed Condition: Hemorrhage; Blood Loss, Surgical; Postoperative Hemorrhage

Efficacy and Safety of Desmopressin (Nocturin®) 0.1 mg Tablets in Treatment of Nocturia in Participants With Benign Prostate Syndrome (BPS)
Status: Completed Condition: Nocturia Associated With Nocturnal Polyuria

Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary
Status: Completed Condition: Nocturia

Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women
Status: Completed Condition: Overactive Bladder

Treatment of Supine Hypertension in Autonomic Failure
Status: Recruiting Condition: Hypertension

Daytime Impact Sleep Study
Status: Terminated Condition: Nocturia

Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin
Status: Recruiting Condition: Chronic Hepatitis C; Chronic Hepatitis B; Biopsy; Hemodialysis

The Effect of Combined Systematized Behavioural Modification Education Program (SyBeMeP) With DDAVP in Patients With Nocturia
Status: Completed Condition: Nocturia

Treatment and Management of Women With Bleeding Disorders
Status: Completed Condition: Menorrhagia; Blood Coagulation Disorders; Blood Platelet Disorders; Von Willebrand Disease; Hematologic Disease

A Study of Minirin Melt in Patients With Nocturia
Status: Completed Condition: Nocturia

A Study of Minirin Melt in Patients With Nocturia
Status: Completed Condition: Nocturia

A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia
Status: Active, not recruiting Condition: Nocturia

MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis
Status: Completed Condition: Nocturnal Enuresis

Platelet Function Analysis in Head Trauma: ASA/Plavix
Status: Completed Condition: Head Injury Trauma Blunt

Platelets Antiaggregation Control Enhancement (PACE) Study
Status: Recruiting Condition: Bleeding; Blood Transfusion

Copeptin for Prediction of Treatment Response in Children With Monosymptomatic Nocturnal Enuresis (MEN).
Status: Not yet recruiting Condition: Nocturnal Enuresis

The Effect of Indomethacin in Monosymptomatic Enuresis Nocturnal
Status: Completed Condition: Enuresis

Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients.
Status: Recruiting Condition: Cocaine Dependence

Phase II Study of IL-11 (Neumega) in Von Willebrand Disease
Status: Completed Condition: Von Willebrand Disease

Study of Novel Types of Familial Diabetes Insipidus
Status: Active, not recruiting Condition: Diabetes Insipidus

Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus
Status: Completed Condition: Diabetes Insipidus; Diabetes Insipidus, Neurohypophyseal

ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders
Status: Completed Condition: Purpura, Thrombotic Thrombocytopenic; Von Willebrand Disease Type-2b

Turkish Acquired Haemophilia Registry
Status: Not yet recruiting Condition: Acquired Haemophilia

V2 Receptor Effects on Fluid Regulation and Performance
Status: Completed Condition: Determine if Sweat [Na+] is Regulated by the V2R

Collection of Blood in Normal Subjects and Subjects With Von Willebrand Disease (VWD)
Status: Withdrawn Condition: Von Willebrand Disease

Nocturnal Enuresis and Rapid Maxillary Expansion
Status: Recruiting Condition: Nocturnal Enuresis

Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension
Status: Recruiting Condition: Essential Hypertension

Long Term Safety Assessment of SER120 in Patients With Nocturia
Status: Completed Condition: Nocturia

RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma
Status: Recruiting Condition: Major Trauma

Thrombocytopathy in Gaucher Disease Patients
Status: Recruiting Condition: Gaucher Disease; Thrombocytopathy

Utilization of iMRI for Transsphenoidal Resection of Pituitary Macroadenomas
Status: Recruiting Condition: Pituitary Macroadenoma

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb
DESMOPRESSIN ACETATE
desmopressin acetate
SPRAY, METERED;NASAL074830-001Jan 25, 1999RXYes<disabled><disabled>
Ferring
DESMOPRESSIN ACETATE
desmopressin acetate
TABLET;ORAL021795-001May 8, 2008RXNo<disabled><disabled>
Ferring Pharms Inc
DDAVP
desmopressin acetate
TABLET;ORAL019955-001Sep 6, 1995RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: desmopressin acetate

These historical archives are available as an add-on to one-year subscriptions

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ferring Pharms Inc
DDAVP
desmopressin acetate
INJECTABLE;INJECTION018938-002Apr 25, 19955,763,407<disabled>
Ferring Pharms Inc
DDAVP
desmopressin acetate
TABLET;ORAL019955-002Sep 6, 19955,500,413<disabled>
Ferring Pharms Inc
DDAVP
desmopressin acetate
TABLET;ORAL019955-002Sep 6, 19955,047,398<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc